Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify a stock or a cryptocurrency in the search bar to get a summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Notable Labs Inc.
NTBLCurrent price
0.08 USD
-0.0009 USD (-1.11%)
Last closed
0.095 USD
Company
–
ISIN
unknown
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Capitalization
2 394 590 USD
Yield for 12 month
-97.54 %
1Y
3Y
5Y
10Y
15Y
NTBL
Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision Medicines Platform (PPMP), bio-simulates a cancer treatment and predicts, whether or not the patient will clinically respond to their actual treatment. Its PPMP is designed to identify and select clinically responsive patients prior to their treatment and enables fast-track therapeutic development in this patient population. The company's pipeline includes Volasertib, a potent Polo-like kinase 1 (PLK-1) inhibitor to induce cell cycle arrest and apoptosis in various cancer cells; and Fosciclopirox, a pro-drug of ciclopirox for acute myeloid leukemia. Notable Labs, Ltd. was incorporated in 2014 and is headquartered in Foster City, California. On October 13, 2024, Notable Labs, Ltd. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware. Address: 320 Hatch Drive, Foster City, CA, United States, 94404
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
9 USDP/E ratio
–Dividend Yield
–Current Year
+310 000 USD
Last Year
+8 000 USD
Current Quarter
+2 000 USD
Last Quarter
+1 000 USD
Current Year
+113 000 USD
Last Year
-1 154 000 USD
Current Quarter
-62 000 USD
Last Quarter
+1 000 USD
Key Figures NTBL
1 year
3 years
5 years
10 years
EBITDA
-15 116 000 USD
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-106.09 %
PEG Ratio
–
Return On Equity TTM
-464.25 %
Wall Street Target Price
9 USD
Revenue TTM
313 000 USD
Book Value
0.74 USD
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
–
Dividend Yield
–
Gross Profit TTM
8 000 USD
Earnings per share
-1.09 USD
Diluted Eps TTM
-1.09 USD
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics NTBL
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NTBL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
1:35
Payout Ratio
–
Last Split Date
17.10.2023
Dividend Date
–
Stock Valuation NTBL
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
7.4129
Price Sales TTM
7.6504
Enterprise Value EBITDA
-0.8318
Price Book MRQ
0.2487
Financials NTBL
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators NTBL
For 52 weeks
0.1 USD
4.24 USD
50 Day MA
0.41 USD
Shares Short Prior Month
622 001
200 Day MA
0.87 USD
Short Ratio
8.21
Shares Short
501 992
Short Percent
8.05 %
BeatStart